Meeting
2014 ASCO Annual Meeting
Pharmacokinetic and pharmacogenetic analysis in patients with advanced nasopharyngeal carcinoma (NPC) treated with 5-flurouracil (5-FU) and cisplatin.
Authors
Yuxiang Ma
Cancer Center, Sun Yat-sen University, Guangzhou, China
Yuxiang Ma , Hongyun Zhao , Liping Zhao , Yunpeng Yang , Cong Xue , Xuan Wu , Wenhua Liang , YuanYuan Zhao , Wenfeng Fang , Tao Qin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 6063)
DOI
10.1200/jco.2014.32.15_suppl.6063
Abstract #
6063
Poster Bd #
98
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Alternative chemoradiotherapy to treat locally advanced (LA) anal carcinoma (AC) in patients (pts) with mutations in thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) genes: A case series.
First Author: Wasif M. Saif
Poster
2018 ASCO Annual Meeting
Comparison between lobaplatin and cisplatin plus 5-fluorouracil combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized phase III clinical trial.
First Author: Kuiyuan Liu
Poster
2013 Gastrointestinal Cancers Symposium
Randomized phase II study of S-1/CDDP plus TSU-68 versus S-1/CDDP in patients with advanced gastric cancer.
First Author: Kensei Yamaguchi
Poster
2012 ASCO Annual Meeting
A phase II study of sorafenib in combination with cisplatin and 5-fluorouracil in the treatment of recurrent or metastatic nasopharyngeal carcinoma.
First Author: Cong Xue